Fine Foods & Pharmaceuticals N.T.M Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 5/6

Fine Foods & Pharmaceuticals N.T.M hat ein Gesamteigenkapital von €129.6M und eine Gesamtverschuldung von €59.6M, wodurch sich der Verschuldungsgrad auf 46% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen €241.0M bzw. €111.3M. Fine Foods & Pharmaceuticals N.T.M Das EBIT des Unternehmens beträgt €6.9M, so dass der Zinsdeckungsgrad 1.5 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von €13.9M.

Wichtige Informationen

47.2%

Verhältnis von Schulden zu Eigenkapital

€60.64m

Verschuldung

Zinsdeckungsgrad	3.3x
Bargeld	€15.21m
Eigenkapital	€128.40m
Gesamtverbindlichkeiten	€111.41m
Gesamtvermögen	€239.81m

Jüngste Berichte zur Finanzlage

Is Fine Foods & Pharmaceuticals N.T.M (BIT:FF) Using Too Much Debt?

Dec 08

Recent updates

Is There An Opportunity With Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s (BIT:FF) 40% Undervaluation?

Apr 28

Estimating The Fair Value Of Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF)

Mar 20

Something To Consider Before Buying Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF) For The 1.1% Dividend

Feb 22

A Look At Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Share Price Returns

Feb 01

What You Need To Know About Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s (BIT:FF) Investor Composition

Jan 14

We Wouldn't Rely On Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Statutory Earnings As A Guide

Dec 28

Is Fine Foods & Pharmaceuticals N.T.M (BIT:FF) Using Too Much Debt?

Dec 08

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: FFDie kurzfristigen Aktiva des Unternehmens (€109.9M) übersteigen seine kurzfristigen Passiva (€66.6M).

Langfristige Verbindlichkeiten: FFDie kurzfristigen Vermögenswerte des Unternehmens (€109.9M) übersteigen seine langfristigen Verbindlichkeiten (€44.8M).

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: FFDie Nettoverschuldung im Verhältnis zum Eigenkapital (35.3%) wird als zufriedenstellend angesehen.

Schulden abbauen: FFDas Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 21.4% auf 46% gestiegen.

Schuldendeckung: FFDie Schulden des Unternehmens sind gut durch den operativen Cashflow gedeckt (47.5%).

Zinsdeckung: FFDie Zinszahlungen für die Schulden des Unternehmens sind durch das EBIT (3.3x Coverage) gut gedeckt.

Fine Foods & Pharmaceuticals N.T.M Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 5/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Is Fine Foods & Pharmaceuticals N.T.M (BIT:FF) Using Too Much Debt?

Recent updates

Second quarter 2024 earnings released

Now 20% undervalued

Upcoming dividend of €0.12 per share

First quarter 2024 earnings released

Now 20% undervalued after recent price drop

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Third quarter 2023 earnings released

Second quarter 2023 earnings released

New major risk - Revenue and earnings growth

Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF) commences an Equity Buyback Plan for 20% of its issued share capital,under the authorization approved on May 9, 2023.

First quarter 2023 earnings released

Upcoming dividend of €0.10 per share at 1.3% yield

Less than half of directors are independent

Consensus forecasts updated

Price target decreased to €11.50

Second quarter 2022 earnings released

First quarter 2022 earnings: Revenues in line with analyst expectations

Upcoming dividend of €0.16 per share

Is There An Opportunity With Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s (BIT:FF) 40% Undervaluation?

Price target decreased to €14.25

Less than half of directors are independent

Full year 2021 earnings: EPS misses analyst expectations

Now 30% undervalued after recent price drop

Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF) made an offer to acquire an additional 24.94% stake in Euro Cosmetic Spa (BIT:EC) for €10.2 million.

Price target decreased to €20.50

Third quarter 2021 earnings released

Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF) signed a binding agreement to acquire a 72.9% stake in Euro Cosmetic S.p.A. (BIT:EC) from Findea's Srl and MD S.R.L. for €26.8 million.

First half 2021 earnings released: €0.26 loss per share

Price target increased to €18.50

Upcoming dividend of €0.14 per share

Full year 2020 earnings released: EPS €0.58 (vs €0.12 loss in FY 2019)

Price target increased to €15.50

Price target increased to €14.90

Consensus EPS estimates fall to €0.52

Full year 2020 earnings released: EPS €0.58 (vs €0.34 in FY 2019)

Estimating The Fair Value Of Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF)

Fine Foods & Pharmaceuticals N.T.M. S.p.A. to Report Fiscal Year 2020 Results on Apr 12, 2021

Something To Consider Before Buying Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF) For The 1.1% Dividend

A Look At Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Share Price Returns

What You Need To Know About Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s (BIT:FF) Investor Composition

We Wouldn't Rely On Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Statutory Earnings As A Guide

Price target raised to €13.50

Is Fine Foods & Pharmaceuticals N.T.M (BIT:FF) Using Too Much Debt?

New 90-day high: €11.30

New 90-day low: €9.76

First half earnings released

New 90-day low: €10.45

New 90-day high - €11.10

Analyse der Finanzlage

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Bilanz

Entdecken Sie finanziell stabile Unternehmen